Health Care: Drugs

Forest Laboratories Inc (FRX: )

$99 -0.77 | -0.77%
06/30/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.28
52 Week High 7.50
52 Week Low 0.63
Avg. Daily Vol. (Mil) 0.01
Beta (3 year) -0.94
Share Related Items
Mkt Cap (Mil) 22.48
Shares Out (Mil) 9.86
Float (Mil) 3.55
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.20
Current Ratio 0.20
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 0.00
Price/Cash Flow -4.50
Per Share Data
Earnings -0.56
Sales 0.00
Book Value 0.00
Cash Flow -0.50
Business Summary
Fennec Pharmaceuticals Inc is a development stage biotechnology company. It is engaged in developing cancer therapeutics. Its products which are in the clinical stage of development are Sodium Thiosulfate and Eniluracil.
General Information
68 TW Alexander Drive
PO Box 13628
Research Triangle, NC 27709
www.fennecpharma.com
Industry : Drugs
Sector: Health Care
Employees: 1
CEO: Mr. Rostislav Raykov
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.01
Short Interest Ratio (Days) 0.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -441.90
Return on Investments 99.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with FRX

Latest FRX Headlines from TheStreet

More Financial News for FRX

Press Releases for FRX

See All Press Releases

Partner Headlines for FRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter